| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.087 | 0.004 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.008 |